3

3

SEC Filing Details

Document Details

Form
Filing Date
Feb 16, 2021
Document Date
02/12/21
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Protalix BioTherapeutics
Issuer
Protalix BioTherapeutics, Inc.
Filer
Dexcel Pharma Technologies Ltd.